Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.05B | $ 4.13B | $ 3.98B | $ 3.54B | $ 2.92B |
| Gross Profit | $ 1.33B | $ 1.50B | $ 1.46B | $ 1.33B | $ 1.07B |
| Operating Income | $ 227.35M | $ 617.26M | $ 650.98M | $ 589.86M | $ 432.73M |
| EBITDA | $ 581.14M | $ 1.03B | $ 986.15M | $ 820.16M | $ 768.47M |
| Net Income | $ 10.30M | $ 474.62M | $ 486.23M | $ 390.98M | $ 364.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 194.61M | $ 276.77M | $ 233.91M | $ 246.30M | $ 229.45M |
| Total Assets | $ 7.53B | $ 8.20B | $ 7.60B | $ 7.02B | $ 5.49B |
| Total Debt | $ 2.72B | $ 3.07B | $ 3.10B | $ 3.21B | $ 2.16B |
| Net Debt | $ 2.53B | $ 2.79B | $ 2.86B | $ 2.96B | $ 1.93B |
| Total Liabilities | $ 4.02B | $ 4.54B | $ 4.58B | $ 4.43B | $ 3.35B |
| Stockholders' Equity | $ 3.46B | $ 3.60B | $ 2.98B | $ 2.53B | $ 2.11B |
| Cash Flow | |||||
| Free Cash Flow | $ 501.61M | $ 365.37M | $ 294.91M | $ 532.03M | $ 380.01M |
| Operating Cash Flow | $ 734.58M | $ 683.90M | $ 619.64M | $ 760.80M | $ 546.58M |
| Investing Cash Flow | $ -245.09M | $ -563.15M | $ -607.92M | $ -1.44B | $ -601.54M |
| Financing Cash Flow | $ -550.93M | $ -85.52M | $ -42.40M | $ 672.60M | $ 47.25M |